GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Onward Medical NV (OTCPK:ONWRF) » Definitions » Debt-to-Asset

Onward Medical NV (Onward Medical NV) Debt-to-Asset : 0.39 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Onward Medical NV Debt-to-Asset?

Onward Medical NV's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.62 Mil. Onward Medical NV's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $17.78 Mil. Onward Medical NV's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was $47.58 Mil. Onward Medical NV's debt to asset for the quarter that ended in Dec. 2023 was 0.39.


Onward Medical NV Debt-to-Asset Historical Data

The historical data trend for Onward Medical NV's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Onward Medical NV Debt-to-Asset Chart

Onward Medical NV Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial 1.45 2.96 0.13 0.19 0.39

Onward Medical NV Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.15 0.19 0.27 0.39

Competitive Comparison of Onward Medical NV's Debt-to-Asset

For the Biotechnology subindustry, Onward Medical NV's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Onward Medical NV's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Onward Medical NV's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Onward Medical NV's Debt-to-Asset falls into.



Onward Medical NV Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Onward Medical NV's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0.619 + 17.782) / 47.578
=0.39

Onward Medical NV's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0.619 + 17.782) / 47.578
=0.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Onward Medical NV  (OTCPK:ONWRF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Onward Medical NV Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Onward Medical NV's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Onward Medical NV (Onward Medical NV) Business Description

Traded in Other Exchanges
Address
High Tech Campus 32, Noord-Braban, Eindhoven, NH, NLD, NL-5656 AE
Onward Medical NV is a medical technology company developing and commercializing therapies to enable functional recovery for people with spinal cord injury. It has developed two programmable neurostimulation platforms: an implantable system, ARCIM, and a non-invasive, transcutaneous system, ARCEX. The company has selected the United states and four European markets: Germany, France, the UK and the Netherlands to create a customer base.

Onward Medical NV (Onward Medical NV) Headlines

No Headlines